8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

Clinical trial NCT00230581 · COMPLETED

Trial details

NCT number: NCT00230581
Sponsor: Dynogen Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2005-09-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.